http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI0721321-A2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_886a6eed19ee9de30a2640e774181b7f |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23C9-206 |
filingDate | 2007-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9cdd3572fbeed5cfa22ec9bbc5d99cc3 |
publicationDate | 2013-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | BR-PI0721321-A2 |
titleOfInvention | use of colostrum and composition |
abstract | USE OF COLOSTRO, AND, COMPOSITION. The invention relates to the treatment of intestinal barrier function disorders involving the administration of a selected colostrum comprising more than 25 wt% undenatured immunoglobulin G (IgG) based on the weight of the total protein content of said colostrum a. an individual. The invention further relates to compositions comprising colostrum and indigestible dietary fibers wherein colostrum comprises more than 25 wt% undenatured immunoglobulin G based on the weight of the total protein content of said colostrum. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115350204-A |
priorityDate | 2007-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 137.